References
- Chen XQ, Peng JW, Lin GN, Li M, Xia ZJ (2012). The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy. Med Oncol, 29, 1237-41. https://doi.org/10.1007/s12032-011-9974-0
- De Mitri MS, Cassini R, Bernardi M (2010). Hepatitis B virusrelated hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Eur J Cancer, 46, 2178-86. https://doi.org/10.1016/j.ejca.2010.03.034
- Deng W, Long L, Li JL, et al (2014). Mortality of major cancers in Guangxi, China: sex, age and geographical differences from 1971 and 2005. Asian Pac J Cancer Prev, 15, 1567-74. https://doi.org/10.7314/APJCP.2014.15.4.1567
- Engels EA, Cho ER, Jee SH (2010). Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol, 11, 827-34. https://doi.org/10.1016/S1470-2045(10)70167-4
- Hatanaka K, Kudo M, Fukunaga T, et al (2007). Clinical characteristics of NonBNonC-HCC: comparison with HBV and HCV related HCC. Intervirology, 50, 24-31. https://doi.org/10.1159/000096309
- Hoofnagle JH (2009). Reactivation of hepatitis B. Hepatology, 49, 156-65. https://doi.org/10.1002/hep.22945
- Jiang XF, Tang QL, Zou Y, et al (2014). Does HBV infection increase risk of endometrial carcinoma? Asian Pac J Cancer Prev, 15, 713-6. https://doi.org/10.7314/APJCP.2014.15.2.713
- Li L, Wu B, Yang LB, Yin GC, Liu JY (2013). Chronic hepatitis B virus infection and risk of pancreatic cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 275-9. https://doi.org/10.7314/APJCP.2013.14.1.275
- Li SL, Su M, Peng T, et al (2013). Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients. Asian Pac J Cancer Prev, 14, 217-23. https://doi.org/10.7314/APJCP.2013.14.1.217
- Lin GN, Peng JW, Xiao JJ, Liu DY, Xia ZJ (2014). Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors. Med Oncol, 31, 119. https://doi.org/10.1007/s12032-014-0119-0
- Liu J, Yang XL, Li A, et al (2014). Epidemiological patterns of cancer incidence in southern China: based on 6 populationbased cancer registries. Asian Pac J Cancer Prev, 15, 1471-5. https://doi.org/10.7314/APJCP.2014.15.3.1471
- Lu FM, Li T, Liu S, Zhuang H (2010). Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat, 17, 4-9. https://doi.org/10.1111/j.1365-2893.2010.01266.x
- Mason A, Wick M, White H, et al (1993). Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology, 18, 781-9. https://doi.org/10.1002/hep.1840180406
- Qiu HB, Zhang LY, Zeng ZL, et al (2011). HBV infection decreases risk of liver metastasis in patients with colorectal cancer: a cohort study. World J Gastroenterol, 17, 804-8. https://doi.org/10.3748/wjg.v17.i6.804
- She J, Yang P, Hong Q, Bai C (2013). Lung cancer in China: challenges and interventions. Chest, 143, 1117-26. https://doi.org/10.1378/chest.11-2948
- Sun Z, Ming L, Zhu X, Lu J (2002). Prevention and control of hepatitis B in China. J Med Virol, 67, 447-50. https://doi.org/10.1002/jmv.10094
- Song E, Chen J, Ou Q, et al (2001). Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection. Am J Surg, 181, 529-33. https://doi.org/10.1016/S0002-9610(01)00634-1
- Srivatanakul P, Honjo S, Kittiwatanachot P, el al (2010). Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand. Asian Pac J Cancer Prev, 11, 985-8.
- Tang Y, Sun LG, Liu CS, et al (2013). Clinical analysis of stages of HBV infection in 100 cases of lymphoma. Asian Pac J Cancer Prev, 14, 959-62. https://doi.org/10.7314/APJCP.2013.14.2.959
- Wei XL, Qiu MZ, Chen WW, et al (2013). The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer. J Transl Med, 11, 249. https://doi.org/10.1186/1479-5876-11-249
- Wu C, Li F, Jiao SC (2012). Prognostic factors for survival of patients with extensive stage small cell lung cancer--a retrospective single institution analysis. Asian Pac J Cancer Prev, 13, 4959-62. https://doi.org/10.7314/APJCP.2012.13.10.4959
- Xie WC, Chan MH, Mak KC, Chan WT, He M (2012). Trends in the incidence of 15 common cancers in Hong Kong, 1983-2008. Asian Pac J Cancer Prev, 13, 3911-6. https://doi.org/10.7314/APJCP.2012.13.8.3911
- Yeo W, Johnson PJ (2006). Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology, 43, 209-20. https://doi.org/10.1002/hep.21051
- Zhao SM, Li HC, Lou H, et al (2001). High Prevalence of HBV in Tibet, China. Asian Pac J Cancer Prev, 2, 299-304.
- Zhu F, Li HR, Du GN, Chen JH, Cai SR (2011). Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China. Asian Pac J Cancer Prev, 12, 1405-8.